MedPath
TGA Approval

DIPENTUM olsalazine sodium 250mg capsule bottle (14466)

14466

DIPENTUM olsalazine sodium 250mg capsule bottle

Atnahs Pharma Australia Pty Ltd

September 5, 1991

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/94ec2239178e9990730960ceed5863ca.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/39b36c17054e16d69cb31e9a2a6ac753.pdf

Active Ingredients

olsalazine sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIPENTUM olsalazine sodium 250mg capsule bottle (14466) - TGA 批准文号 | MedPath